พบ "Public health policy"ทั้งหมด 1,226 ผลลัพธ์
เรียงลำดับตาม
ฮ - ก

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand.(2010)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand Jomkwan Yothasamut1, Choenkwan Putchong1, Teera Sirisamutr1, Yot Teerawattananon1, Sripen Tantivess1,2* 1Health Intervention and Technology Assessment Program, Ministry of Public Health,

Saudamini Vishwanath Dabak

Saudamini Dabak is the Head of HITAP’s International Unit (HIU). She started working at HITAP as an Overseas Development Institute (ODI) Fellow in 2015. At HITAP, Saudamini has supported Health Technology Assessment (HTA) initiatives in Asia and Africa and has also been involved in conducting health systems research. Prior to working at HITAP, Saud

Sarin K C

Sarin KC is Head of the Environmental Economics Unit at HITAP, Ministry of Public Health, Thailand. Previously, he worked as a research analyst at the London School of Economics and Political Science (LSE) and the Ministry of Health and Population in Nepal.As a health economist, he has helped institutionalise Health Technology Assessment (HTA) in c

SAPPHIRE

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

Sanofi pulls leukaemia drug ahead of possible OK for Lemtrada

(Reuters) – Sanofi’s rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.The withdrawal, meant to prevent the off-label use of Campath as a multiple sclerosis drug, is al

SAFE เพื่อหลักประกันสุขภาพที่ยั่งยืน “หมอทุกคนต้องรู้เรื่องการประเมินเทคโนโลยีฯ”

ประเทศไทยมีระบบหลักประกันสุขภาพถ้วนหน้าช่วยให้คนไทยทุกคนได้เข้าถึงการรักษาพยาบาลได้ฟรี ทว่าค่าใช้จ่ายที่ตามมาแท้จริงแล้วคือสิ่งที่ประเทศต้องแบกรับ ภาระค่าใช้จ่ายด้านสุขภาพของประเทศเพิ่มขึ้นตามความต้องการการรักษาพยาบาลของคนไทย จากคำกล่าวของผู้คร่ำหวอดในวงการ นพ.สุวิทย์ วิบุลผลประเสริฐ SAFE report คือ

Role of priority setting in implementing universal health coverage.

Yot Teerawattananon programme leader1, Alia Luz project associate2, Churnrurtai Kanchanachitra director, Mahidol University Global Health 3, Sripen Tantivess senior researcher 1, On behalf of the Prince Mahidol Award Conference secretariat 1Health Intervention and Technology Assessment Program (

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?

Abstract There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that

Rise in UK drug-resistant tuberculosis cases

Cases of drug-resistant tuberculosis (TB) in the UK have risen by over a quarter in the last year, the Health Protection Agency (HPA) has revealed.In 2011, 431 cases did not respond to antibiotic treatment compared to 342 in 2010, the HPA said. About 550 more cases of TB were disgnosed in 2011.The a

Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis

Abstract Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care’s benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impac
10 / หน้า